{"id":7461,"date":"2021-12-16T08:01:30","date_gmt":"2021-12-16T13:01:30","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/lanreotidacetat-cas-127984-74-1-behandlung-von-akromegalie-und-symptomatischen-neuroendokrinen-tumoren\/"},"modified":"2021-12-16T08:01:30","modified_gmt":"2021-12-16T13:01:30","slug":"lanreotidacetat-cas-127984-74-1-behandlung-von-akromegalie-und-symptomatischen-neuroendokrinen-tumoren","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/de\/product\/lanreotidacetat-cas-127984-74-1-behandlung-von-akromegalie-und-symptomatischen-neuroendokrinen-tumoren\/","title":{"rendered":"Lanreotidacetat CAS 127984-74-1 Behandlung von Akromegalie und symptomatischen neuroendokrinen Tumoren"},"content":{"rendered":"

Lanreotidacetat CAS 127984-74-1 Behandlung von Akromegalie und symptomatischen neuroendokrinen Tumoren<\/strong><\/h2>\n

Produktname: Lanreotidacetat
\nSynonyme: 10-(4-Aminobutyl)-19-[(2-amino-3-naphthalin-2-yl-propanoyl)amino]-N-(1 -carbamoyl-2 -hydroxy-propyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol -3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1 ,2-Dithia-5,8,11,14, 17-Pentazacycloicosan-4-carboxamid;Somatulina;LANREOTIDACETAT;3-(2-Naphthalenyl)-D-Alanyl-L-Cysteinyl-L-Tyrosyl-D-Tryptophyl- L-Lysyl-L-valyl-L-cysteinyl-L-threoninamid cyclisches (2\u21927)-disulfidacetat;Angiopeptinacetat;10-(4-Aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan -2-yl)-19-[(2-amino-3-naphthalin-2-ylpropanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6, 9,12,15,18-Pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-Pentazacycloicosan-4-carboxamid;Lanreotidacetat USP\/EP\/BP
\n CAS: 127984-74-1
\nMF: C54H69N11O10S2
\nMW: 0
\nEINECS:
\nProduktkategorien: Aminos\u00e4uren & Derivate, Pharmazeutika, Zwischenprodukte & Derivate
\nMol File: 127984-74- 1.mol<\/p>\n

Lanreotidacetat, ein Octapeptid-Somatostatin analog, erreichte in Frankreich seinen ersten weltweiten Markt f\u00fcr Akromegalie, als eine Operation oder Strahlentherapie die normale Wachstumshormonsekretion nicht wiederherstellen konnte. Lanreotid ist ein selektiver Wachstumshormonhemmer und reduziert die Sekretion von Wachstumshormon, Thyrotropin, Motilin und Pankreaspolypeptid beim Menschen. Lanreotid hat antiproliferative Eigenschaften und befindet sich Berichten zufolge in klinischen Studien zur Vorbeugung von Restenose nach Koronararterien-Angioplastie, bei diabetischer Retinopathie und als Therapie bei Psoriasis. Sein Potenzial f\u00fcr neuroendokrine Tumoren und hormonabh\u00e4ngigen Prostatakrebs wurde ebenfalls nachgewiesen.<\/p>\n

Lanreotidacetat CAS 127984-74-1 Chemische Eigenschaften<\/strong>
\nLagertemp. -20\u00b0C
\nFormpulver
\nFarbe wei\u00df bis cremefarben<\/p>\n

Funktion und Anwendung von Lanreotidacetat CAS 127984-74-1<\/strong>
\nLanreotidacetat, wie nat\u00fcrliche Wachstumshemmer, Lanreotid ist a Peptidinhibitor vieler endokriner, neuroendokriner, exokriner und parakriner Funktionen. Lanreotid ist aktiver und hat eine l\u00e4ngere Wirkungsdauer als nat\u00fcrliche Wachstumshemmer. Seine hemmende Wirkung auf die Wachstumshormonsekretion ist deutlich selektiver als die auf die Insulinsekretion, und 2017 hat die FDA Lanreotidacetat zur Injektion zur Behandlung neuroendokriner Tumoren zugelassen.<\/p>\n","protected":false},"excerpt":{"rendered":"

Produktname: Lanreotidacetat
\nCAS: 127984-74-1
\nMF: C54H69N11O10S2
\nMol Datei: 127984-74-1.mol<\/p>\n","protected":false},"featured_media":2102,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[396],"product_tag":[2310],"class_list":{"0":"post-7461","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-tumor-peptid-de","7":"product_tag-lanreotide-acetate-cas-127984-74-1-treat-for-acromegaly-and-symptomatic-neuroendocrine-tumors-de","8":"desktop-align-left","9":"tablet-align-left","10":"mobile-align-left","12":"first","13":"instock","14":"shipping-taxable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/product\/7461","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/comments?post=7461"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/media\/2102"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/media?parent=7461"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/product_brand?post=7461"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/product_cat?post=7461"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/product_tag?post=7461"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}